Engitix Ltd: Valuation, Funding & Investors
Engitix is a biotech company developing therapies that target the extracellular matrix (ECM) to treat cancer and fibrosis. The company integrates large-scale ECM datasets with translational biology and drug development to build a pipeline of therapeutics designed to act within diseased tissue microenvironments.
Leadership & Board
- Current Number of Employees
- 65
- Current LinkedIn Followers
- 10,101
Latest Estimated Valuation
- Total Amount Raised
- $25M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $25M
- Latest Funding Round
- Series A
Employee Trend
Engitix Ltd had 65 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
65Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Engitix Ltd had 10,101 followers as of November 9, 2026. The number of followers increased by 75 (0.75%) week-over-week.
10,101Latest Followers Count
75(0.75%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 08, 2026 | Series A | $25.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Netherton Investments | Series A |
| Mike Platt | Series A |
Similar Companies
A snapshot of private companies similar to Engitix Ltd, helping you discover and navigate related company profiles.







